Factor IX encoding nucleotides
US10842885B2 · kind B2 · utility
1Cited by
8References
24Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 20, 2018 |
| Grant date | Nov 24, 2020 |
| Priority date | — |
| Expiry date | Aug 20, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Y304/21022
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to polynucleotides comprising a Factor IX nucleotide sequence, wherein the Factor IX nucleotide sequence comprises a coding sequence that encodes a Factor IX protein or fragment thereof and wherein a portion of the coding sequence is not wild type. The present invention further relates to viral particles comprising a recombinant genome comprising the polynucleotide of the invention, compositions comprising the polynucleotides or viral particles, and methods and uses of the polynucleotides, viral particles or compositions.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.